Teva

Copaxone first on FDA’s list for faster complex generic approvals

https://pharmaphorum.com/news/mylan-targets-teva-ms-blockbuster-copaxone-us/

Huntington’s Disease wearable gets backing from NIH

https://pharmaphorum.com/news/huntingtons-disease-wearable-nih/

Teva sells women’s health division to tackle $35bn debts

https://pharmaphorum.com/news/teva-sells-womens-health-business-bid-tackle-debts/

Teva appoints Lundbeck’s Kare Schultz as CEO

https://pharmaphorum.com/news/teva-kare-schultz-ceo/

Bidders lining up for Teva women’s health unit

https://pharmaphorum.com/news/bidders-lining-teva-womens-health/

Roche’s Herceptin facing further biosimilar threats in US

https://pharmaphorum.com/news/roches-herceptin-facing-biosimilar-threats-us/

Teva’s Cinqaero to challenge Nucala after clearing NICE

https://pharmaphorum.com/news/nice-recommends-teva-asthma-drug/

EU authorities accuse Teva of breaking competition rules

https://pharmaphorum.com/news/eu-teva-competition-rules/

AstraZeneca CEO Soriot may stay after all

https://pharmaphorum.com/news/astrazeneca-ceo-soriot-may-stay/

«< 5 6 7 8 9 >»

Close in 10 seconds

Pharmaphorum.com

Search